Search

Search Constraints

You searched for: Author/Creator Noble, Paul W

Search Results

1. CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trial. Issue 1 (20th January 2022)

2. Dose modification and dose intensity during treatment with pirfenidone: analysis of pooled data from three multinational phase III trials. Issue 1 (2nd August 2018)

3. Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis. Issue 5 (11th March 2016)

4. Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis. Issue 1 (January 2017)

5. Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial. Issue 1 (January 2017)

6. Risk factors for disease progression in idiopathic pulmonary fibrosis. Issue 1 (14th October 2019)

7. Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials. Issue 1 (12th January 2016)

8. Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?. Issue 2 (February 2018)